Agios Pharmaceuticals Inc (AGIO)

SG&A Expense Growth

6.71%

Quarterly · Period ending:

AGIO logo

AGIO SG&A Expense Growth

Latest reported6.71%
AGIO Quarterly SG&A Growth (QoQ) (0.00% → 6.71%)
High-resolution chart · PNG

AGIO sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Agios Pharmaceuticals Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
6.7137%
-6.4057%
25.0424%
-10.0177%
10.4558%
-19.6723%
34.149%
8.445%
14.5805%
-12.1541%
36.7245%
-6.9612%
7.7449%
-14.7279%
13.5212%
3.2155%
-11.3415%
-0.1408%
17.4999%
-7.7739%
-13.6864%
-21.7331%
14.1734%
-3.0903%
-6.6232%
10.5271%
5.4968%
1.942%
1.8842%
-0.2103%
2.4241%
16.7874%
8.4847%
8.0879%
30.1008%
8.2331%
8.8174%
-3.6153%
29.7368%
-6.248%
16.6744%
6.4329%
2.5688%
11.1771%
28.4009%
6.9682%
25.842%
24.0336%
26.6727%
-11.3029%
46.2904%
38.0174%
-0.8639%
19.1763%
-1.6456%
-18.8912%
-1.6658%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.